174 related articles for article (PubMed ID: 17825390)
21. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
Giguère Y; Dewailly E; Brisson J; Ayotte P; Laflamme N; Demers A; Forest VI; Dodin S; Robert J; Rousseau F
Cancer Res; 2001 Aug; 61(15):5869-74. PubMed ID: 11479228
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite profile in hormonal receptor genes associated with breast cancer.
Iobagiu C; Lambert C; Normand M; Genin C
Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.
Strom SS; Gu Y; Zhang H; Troncoso P; Babaian RJ; Pettaway CA; Shete S; Spitz MR; Logothetis CJ
Prostate; 2004 Sep; 60(4):343-51. PubMed ID: 15264247
[TBL] [Abstract][Full Text] [Related]
24. Effect of cigarette smoking on epithelial ovarian cancer survival.
Ioffe YJ; Elmore RG; Karlan BY; Li AJ
J Reprod Med; 2010; 55(7-8):346-50. PubMed ID: 20795350
[TBL] [Abstract][Full Text] [Related]
25. Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.
Di Fabio F; Alvarado C; Gologan A; Youssef E; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
J Surg Res; 2009 Jun; 154(1):38-44. PubMed ID: 19062046
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism.
Ibáñez L; Ong KK; Mongan N; Jääskeläinen J; Marcos MV; Hughes IA; De Zegher F; Dunger DB
J Clin Endocrinol Metab; 2003 Jul; 88(7):3333-8. PubMed ID: 12843184
[TBL] [Abstract][Full Text] [Related]
27. Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy.
Zeigler-Johnson C; Weber A; Spangler E; Panossian S; Rebbeck TR; Malkowicz SB
Prostate; 2012 Jun; 72(9):984-90. PubMed ID: 22025404
[TBL] [Abstract][Full Text] [Related]
28. Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.
Fotopoulou C; Richter R; Braicu EI; Kuhberg M; Feldheiser A; Schefold JC; Lichtenegger W; Sehouli J
Ann Surg Oncol; 2011 Sep; 18(9):2629-37. PubMed ID: 21394662
[TBL] [Abstract][Full Text] [Related]
29. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
[TBL] [Abstract][Full Text] [Related]
30. CAG repeat polymorphism in the androgen receptor gene in women with rheumatoid arthritis.
Dziedziejko V; Kurzawski M; Safranow K; Ossowski A; Piatek J; Parafiniuk M; Chlubek D; Pawlik A
J Rheumatol; 2012 Jan; 39(1):10-7. PubMed ID: 22089459
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
[TBL] [Abstract][Full Text] [Related]
32. [Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report].
Bidzińska-Speichert B; Demissie M; Tworowska U; Slezak R; Dobosz T; Bednarek-Tupikowska G; Milewicz A
Przegl Lek; 2005; 62(9):833-7. PubMed ID: 16541712
[TBL] [Abstract][Full Text] [Related]
33. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
34. AIB1 polymorphisms predict aggressive ovarian cancer phenotype.
Li AJ; Lerner DL; Gapuzan ME; Karlan BY
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2919-22. PubMed ID: 16365010
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
[TBL] [Abstract][Full Text] [Related]
36. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
[TBL] [Abstract][Full Text] [Related]
37. Body mass index in relation to ovarian cancer survival.
Zhang M; Xie X; Lee AH; Binns CW; Holman CD
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1307-10. PubMed ID: 15894691
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Andersson P; Varenhorst E; Söderkvist P
Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
[TBL] [Abstract][Full Text] [Related]
39. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.
De Abreu FB; Pirolo LJ; Canevari Rde A; Rosa FE; Moraes Neto FA; Caldeira JR; Rainho CA; Rogatto SR
Anticancer Res; 2007; 27(2):1199-205. PubMed ID: 17465263
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
Yoshihara K; Tajima A; Komata D; Yamamoto T; Kodama S; Fujiwara H; Suzuki M; Onishi Y; Hatae M; Sueyoshi K; Fujiwara H; Kudo Y; Inoue I; Tanaka K
Cancer Sci; 2009 Aug; 100(8):1421-8. PubMed ID: 19486012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
